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CD95-Induced Apoptosis of Lymphocytes
in an Immune Privileged Site
Induces Immunological Tolerance
Thomas S. Griffith,* Xinhong Yu,* chamber (AC) of the eye (called anterior chamber–
associated immune deviation, ACAID) was initially de-John M. Herndon,* Douglas R. Green,‡
and Thomas A. Ferguson*† scribed by Kaplan and Streilein (1977). These authors
observed that the injection of F1 spleen cells into the*Department of Ophthalmology and Visual Sciences
†Department of Pathology AC resulted in the induction of an antibody response
to donor alloantigens, but these animals displayed anWashington University School of Medicine
St. Louis, Missouri 63110 impaired capacity to reject allografts from the donor
strain used for AC priming. Subsequent studies have‡The La Jolla Institute for Allergy and Immunology,
Division of Cellular Immunology extended these observations to a number of antigens,
including hapten-coupled spleen cells (Ferguson et al.,La Jolla, California 92037
1987, 1989; Wetzig et al., 1982), viruses (Streilein et al.,
1987; Whittum-Hudson et al., 1985), corneal allografts
(Sonada and Streilein, 1993), and tumor cells (StreileinSummary
and Niederkorn, 1981). It is now generally accepted that
the injection of antigen into the AC results in the induc-We examined the relationship between cell death and
tion of an antibody response, with simultaneous impair-tolerance induction following antigen injection into the
ment (or tolerance) of delayed-type hypersensitivityanterior chamber of the eye. Our data show that when
(DTH). It is well known that DTH tolerance is not simplyinflammatory cells undergo apoptosis following infec-
the failure to prime, but results in thegeneration of activetion with HSV-1, tolerance to the virus was observed.
regulatory cell function (Ferguson et al., 1987, 1989,In contrast, when cell death was absent due to defects
1995; Kaplan and Streilein, 1977; Taylor et al., 1994;in Fas or FasL, immune tolerance was not observed.
Streilein et al., 1987; Sonada and Streilein, 1993; WetzigFurther studies revealed that cell death and tolerance
et al., 1982; Wilbanks and Streilein, 1992; Wilbanks etrequired that the lymphoid cells be Fas1 and the eye
al., 1991, 1992). It is thought that this tolerance imposedbe FasL1. Additionally, we show that while Fas/FasL-
on DTH reactions relates to immune privilege and is amediated apoptosis occurred in the eye, it was apop-
mechanism by which important ocular structures aretotic cell death that was critical for tolerance induction.
protected from rampant inflammatory reactions associ-Our results further demonstrate immune privilege is
ated with DTH responses. Tolerance induction via thenot a passive process involving physical barriers, but
eye is also dependent on the local immunosuppressiveis an active process that employs an important natural
environment composed of tumor growth factor-b (Wil-mechanism to induce cell death and immune tol-
banks and Streilein, 1992; Wilbanks et al., 1992) anderance.
neuropeptides (Ferguson et al., 1995; Taylor et al., 1994),
and intraocular antigen-presenting cells (Kinesely et al.,Introduction
1991; Wilbanks et al., 1991), but studies have also re-
vealed that T cells (Ferguson et al., 1987; Griffith et al.,The immune privilege of the eye is comprised of a num-
1995b; Whittum-Hudson et al., 1985), the spleen (Strei-ber of factors that control local and systemic immune
lein and Niederkorn, 1981), and an intact eye for 3 daysresponses to prevent inflammatory damage to this im-
postinjection (Streilein et al., 1987; Wilbanks and Strei-portant organ. These include the presence of immuno-
lein, 1989) are required for tolerance induction. Thesesuppressive cytokines (Hooper et al., 1991; Wilbanks
attributes demonstrate the unique way in which im-and Streilein, 1992; Wilbanks et al., 1992) and neuropep-
mune-privileged sites deal with foreign antigens andtides (Ferguson et al., 1995; Taylor et al., 1994) within
suggest that important local (i.e., intraocular) mecha-the ocular environment, the strategic localization of
nisms contribute to systemic tolerance induction. Stud-phagocytic cells in the eye (Kinesely et al., 1991; Wil-
ies presented here further examine this mode of toler-banks et al., 1991), and the ability to induce immune
ance induction and explore the relationship between thedeviation following antigen presentation in the eye (Fer-
destruction of invading cells by FasL-induced apoptosisguson et al., 1987, 1989, 1995; Kaplan and Streilein,
in the eye and the induction of systemic immune devi-1977; Sonada and Streilein, 1993; Streilein et al., 1987;
ation.Wetzig et al., 1982). Additionally, immune privilege also
relates to the constitutive expression of Fas ligand
(FasL) on ocular tissue capable of inducing cell death Results
in invading inflammatory cells (Griffith et al.,1995a). FasL
is found on important ocular structures such as the ret- The Role of the Intact Eye in Tolerance Induction
It is well established that the injection of antigen intoina and cornea, and its importance in maintaining the
integrity of the eye was demonstrated, since defective the AC results in the induction of immune deviation (Fer-
guson et al., 1987, 1989, 1995; Kaplan and Streilein,FasL resulted in uncontrolled inflammatory responses
during a viral infection. The expression of FasL in testis 1977; Sonada and Streilein, 1993; Streilein et al., 1987;
Wetzig et al., 1982), thehallmark of which is the tolerance(Bellgrau et al., 1995) suggests it may be of general
importance to the integrity of immune privileged sites. of the DTH response. Additionally, we have recently
demonstrated that inflammatory infiltrates entering theThe induction of immune deviation via the anterior
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Figure 1. Effect of Enucleation on Tolerance Induction
B6 mice were injected AC with 2.5 3 104 pfu of HSV-1. On days 1,
2, 3, and 4 eyes were removed. On day 7, mice were challenged
with 106 pfu UV-inactivated virus in 0.033 ml PBS in the right foot-
pad and 0.033 ml PBS in the left footpad. Measurements (micro-
meters 6 standard error) were taken 24 hr later and represent the
difference between right footpad (antigen challenge) and left foot-
pad (PBS challenge). Background (Bkg) values represent the differ-
ence between challenged and unchallenged sites in naive mice.
eye at 48 hr following viral injection underwent apoptosis
mediated by Fas/FasL (Griffith et al., 1995a). Thus, the
question arose as to whether apoptosis of the inflamma-
tory cells in the eye and systemic tolerance were related.
We initiallyaddressed this by performing the enucleation
experiment described in Figure 1 where mice were in-
jected in the AC with 2.5 3 104 pfu HSV-1 (KOS) cells,
and on days 1, 2, 3, and 4 certain groups were enucle-
ated. These results show that enucleation on days 1–2
resulted in theestablishment of immunity to HSV-1; mice
enucleated on day 3 showed an intermediate response;
while mice enucleated on day 4 became tolerant. Thus,
an intact eye for at least 3 days was required to establish
tolerance, while removal of the eye prior to this led to
immunity. Since the cells entering the eye die within 48 Figure 2. Immune Tolerance in B6–lpr or B6–gld Mice
hr of viral injection, this suggested that perhaps the B6–lpr (A), B6–gld (B), or B6 mice were immunized with 2.5 3 104
intact eye containing the apoptotic cells might be re- pfu of HSV-1 either AC or subcutaneously. They were challenged 7
days later with 106 pfu UV-inactivated virus in 0.033 ml PBS in thequired to establish tolerance.
right footpad and 0.033ml PBS in the left footpad. Measurements
(micrometers 6 standard error) were taken 24 hr later and represent
the difference between right footpad (antigen challenge) and leftLack of Tolerance in lpr or gld Mice
footpad (PBS challenge). Background (Bkg) values represent theFollowing HSV-1 Injection
difference between challenged and unchallenged sites in naive
To address further the relationship between apoptosis mice.
and tolerance, we examined B6–lpr and B6–gld. Mice
with the lpr mutation are defective in Fas (Watanabe-
Fukunaga et al., 1992), while those with the gld defect 2 shows that tolerance was induced only in B6 mice
following AC injection (Figures 2A and 2B), while B6–lprare deficient in functional FasL (Takahashi et al., 1994).
Inflammatory cells in B6–lpr and B6–gld mice induced (Figure 2A) or B6–gld (Figure 2B) mice developed immu-
nity similar to that induced by subcutaneous injectionby HSV-1 did not undergo apoptosis in these animals
(Griffith et al., 1995a). These mice were injected in the of virus.
We then examined cytokine production following in-AC with 2.5 3 104 pfu HSV-1 (KOS) and challenged 7
days later in the footpad with 106 ultraviolet (UV)-inacti- jection of HSV-1 into the AC. B6 and B6–gld mice were
injected in the AC or intraperitoneally with 2.5 3 104vated virus to assess the DTH response. Data in Figure
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placement of cells in the AC and examine the role ofTable 1. IFN ga Production in Spleens of B6 and B6–gld Mice
Following Injection of HSV-1 Fas on the lymphoid cells and FasL in the eye more
directly. In this system, 5 3 105 TNP-coupled spleen cellStrain Injection Route IFN ga U/ml
were injected into the AC, followed 48 hr later with skin
B6 Anterior chamber 4.4 6 0.2 sensitization with 1% 2,4,6-trinitro-1-chlorobenzene
B6–gld Anterior chamber 23.1 6 1.5
(TNCB) in acetone/olive oil. Mice were challenged in theB6 (Day 2 enucleation)b Anterior chamber 22 6 3
footpad 5 days later with 10 mM 2,4,6 trinitrobenzeneB6 Intraperitoneal 51 6 2
sulfonic acid (TNBS) and the response assessed 24 hrB6–gld Intraperitoneal 92 6 4
later by measuring footpad thickness. Figure 4 showsa IFN g tested in 48 hr culture supernatants of spleen cells. Mice
that immune tolerance was established when B6 TNP–were injected AC or intraperitoneally with 2.5 3 104 HSV-1 and 7
spl were injected into the AC of B6 or B6–lpr mice.days later spleens were removed and cultured with 1 3 106 UV-
inactivated HSV-1 for 48 hrs. Likewise, when B6–gld TNP–spl were injected into B6
b The eye was removed on day 2 following HSV-1 injection. recipients, tolerance was observed. However, when B6
TNP–spl were injected into B6–gld mice or B6–lpr TNP–
spl were injected into B6 mice, immune deviation was
HSV-1 and the spleen was removed 7 days later. Spleen not observed.
cells were then cultured with 106 UV-inactivated virus in The involvement of Fas and FasL (and where they
vitro and supernatants were harvested at 48 hr. Super- must be present) suggested the possibility that Fas-
natants were then examined for the presence of inter- induced apoptosis may also play a role in the induction
feron-g (IFNg). As shown in Table 1, B6 mice injected of tolerance in this system. Indeed, we found that toler-
in the AC and tolerant to HSV-1 antigens elaborate sig- ance correlated with apoptosis in the TNP–spl popula-
nificantly less IFNg following stimulation compared with tion. As shown in Figure 5A, numerous TUNEL1 cells
the nontolerant B6–gld mice. B6 mice enucleated on were found in the eye 48 hr following AC injection of
day 2 (see Figure 1, immune) also produce IFNg at the B6–TNP–spl into B6 mice. In contrast, when TNP–spl
same level as that in AC-injected B6–gld mice. Thus, from B6–lpr mice were used, apoptotic (TUNEL1) cells
tolerance in this response (DTH) was reflected by an were not observed (Figure 5B). Similarly, when B6–gld
inability to produce a T helper 1 (Th1) cytokine. mice were used as recipients for B6 TNP–spl, TUNEL1
cells were not observed (Figure 5C). Thus, Fas must be
Restoration of Tolerance in B6→B6–lpr present on the injected cells, while FasL must be present
Bone Marrow Chimeras in the eye for tolerance to follow.
Unlike B6 mice, Fas-defective B6–lpr mice do not have
apoptotic cells as detected by TUNEL staining in the
eye following viral infection (Griffith et al., 1995a). Addi- The Role of Apoptosis in Immune Tolerance
Data thus far suggested a link between FasL-inducedtionally, B6–lpr mice also do not develop tolerance fol-
lowing AC injection of the virus (Figure 2A). Thus, we cell death in the eye and the induction of tolerance. It
was possible that apoptotic cell death was the criticaltested whether we could restore tolerance to B6–lpr
mice with normal B6 lymphoid cells. Bone marrow chi- factor. We have previously shown that tolerance induc-
tion via the AC required the T cell fraction of spleenmeras were prepared in which lethally irradiated B6–lpr
mice were reconstituted with bone marrow and spleen (Ferguson et al., 1987, 1989; Griffith et al., 1995b) and
cells that were chemically fixed, killed by freeze/thaw,from B6 animals. Mice were injected AC 3–4 weeks fol-
lowing reconstitution with HSV-1 and the establishment or treated with metabolic inhibitors were not functional
(Ferguson et al., 1987, 1989). Here, we performed a simi-of tolerance examined. Figure 3A shows that B6–lpr
reconstituted with B6 bone marrow displayed immune lar experiment using B6–lpr TNP T cells, which do not
have functional Fas and cannot be induced to undergotolerance to HSV-1. Figure 3B shows a TUNEL stain
from these mice 48 hr postinfection. Unlike B6–lpr mice apoptosis by the FasL in the eye. B6–lpr T cells were
treated with g irradiation, heat shock, paraformaldehyde(Figure 3C; Griffith et al., 1995a), numerous apoptotic
cellswere found in the B6→B6–lprchimeras. Thus,when fixation, or freeze/thaw and then placed in the AC. Mice
were immunized 48 hr later with TNCB and tolerancecells were present that can undergo Fas-mediated cell
death, immune tolerance was reestablished in B6–lpr assessed 5 days later. As shown in Figure 6A, cells fixed
with paraformaldehyde or subjected to freeze/thaw (F/T)mice.
did not induce tolerance; however, cells g irradiated or
heat treated did. Examination of the DNA from theTolerance Induced by TNP–spl System
The above results suggest that tolerance to HSV-1 was treated cells revealed DNA fragmentation in g irradiated
or heat-treated cells, but not from fixed or freeze/thawedpresent only when apoptosis was induced in the eye
following viral infection. One possibility was that the cells (Figure 6B). The failure of B6–lpr TNP–spl to invoke
tolerance was corrected when the TNP–spl cells werepresence of apoptosis induced by Fas/FasL interactions
contributes to the induction of tolerance in this system. rendered apoptotic, but not when the cells were killed
via necrosis. This suggests that it was apoptosis, perTo explore further this relationship, we examined the
inductionof tolerance by the injection of hapten-coupled se, that provided that requisite signal for tolerance, and
not any special aspect of Fas/FasL signaling.lymphoid cells (trinitrophenol-coupled spleen cells
[TNP–spl]) into the AC. This well-characterized system The experiment in Figure 7 examined tolerance induc-
tion using TNP-coupled cells from Bcl-xL transgenic(Ferguson et al., 1987, 1989, 1994, 1995; Griffith et al.,
1995b; Wetzig et al., 1982) allowed us to control the mice whose T cells overexpress Bcl-xL (Chao et al.,
Immunity
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Figure 3. Immune Tolerance and Apoptosis
in Chimeric B6→B6–lpr Mice
(A) B6, B6–lpr, or B6→B6–lpr chimeric mice
were immunized with 2.5 3 104 pfu of HSV-1
either AC or subcutaneously. They were chal-
lenged 7 days later with 106 pfu UV-inacti-
vated virus in 0.033 ml PBS in the right foot-
pad and 0.033 ml PBS in the left footpad.
Measurements (micrometers 6 standard er-
ror) were taken 24 hr later and represent the
difference between right footpad (antigen
challenge) and left footpad (PBS challenge).
Background (Bkg) valuesrepresent the differ-
ence between challenged and unchallenged
sites in naive mice.
(B) TUNEL stain of inflammatory cells infiltrat-
ing the eye of B6→B6–lpr chimeric mice 48
hr after injection of 2.5 3 104 HSV-1.
(C) TUNEL stain of inflammatory cells infiltrat-
ing the eye B6–lpr mice 48 hr after injection
of 2.5 3 104 HSV-1. AC, anterior chamber; C,
cornea; IR, iris; L, lens.
1995). Bcl-xL, like Bcl-2 (Iwai et al., 1994), has been 1995). Here, we show that Bcl-xL TNP-coupled cells do
not induce immune deviation in B6 mice. Thus, fromshown to protect cells from apoptotic cell death, and it
has recently been shown that Bcl-xL can block Fas/ Figures 6 and 7, and our previous data (Ferguson et al.,
1987, 1989), we conclude that it is apoptotic cell deathFasL-induced cell death (Chao et al., 1995; Boise et al.,
Apoptosis and Tolerance
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et al., 1995a). The Fas/FasL system of cell death has
been shown to be involved in clonal deletion in the pe-
riphery (Mogil et al., 1995; Singer and Abbas, 1994),
down-regulation of immune reactions (Nagata and Suda,
1995), and killing by cytotoxic T cells (Rouvier et al.,
1993). It is also involved in preventing rejection of im-
mune-privileged tissue (Sertoli cells from the testis)
when transplanted to the kidney capsule (Bellgrau et al.,
1995). Here, we show the induction of immune tolerance
following antigen injection into the eye depends on the
death of lymphoid cells in the eye by the Fas/FasL sys-
tem. Although Fas/FasL-induced death is the mecha-
nism by which cells are killed in the eye, it is the apop-
totic cell death that was critical. Cells induced to
undergo apoptosis by other means prior to injection into
the eye can induce tolerance, while necrotic cells do
not. We conclude that this immune-privileged site has
linked two important natural mechanisms, apoptosis
and tolerance, for protection from rampant inflammatory
reactions and perhaps autoimmunity.Figure 4. Immune Tolerance Requires Functional Fas Expression
on Injected Spleen Cells and Functional FasL Expression in the Eye The induction of tolerance following AC injection of
antigen requires that a number of factors must work inB6, B6–lpr, or B6–gld mice were injected AC with 5 3 105 TNP–spl
from B6, B6–lpr, or B6–gld mice 48 hr before immunization with 1% concert. First, an intact antigen-containing eye is re-
TNCB on shaved abdominal skin. Mice were challenged 5 days later quired for the first 3 days following AC injection (Streilein
with 0.033 ml 10 mM TNBS in PBS in the right footpad and 0.033 et al., 1987; Wilbanks and Streilein, 1989). This sug-
ml PBS in the left footpad. Measurements (micrometers 6 standard
gested that interactions within the confines of the ocularerror) were taken 24 hr later and represent the difference between
immunosuppressive environment early in the responseright footpad (antigen challenge) and left footpad (PBS challenge).
were essential. We have observed apoptotic cells withinBackground (Bkg) values represent the difference between chal-
lenged and unchallenged sites in naive mice. the first 24–48 hr and that removal of the eye prior to
day 4 abolished tolerance and established immunity
(Figure 1). Thus, the 3 day requirement for the intact eye
of T cells in the eye that leads to systemic immune may involve the need for the induction of apoptosis in
tolerance induction. the inflammatory cells. The fate of the apoptotic cells
has not been determined, but we have observed that
Discussion they have disappeared from the eye by 72–96 hr (data
not shown). Second, T cells reacting locally (i.e., in the
The concept of an immune-privileged site dates back eye) are critical to induce tolerance for many antigens
over 120 years (VanDooremaal, 1873) and has been ap- (Ferguson et al., 1987, 1989; Griffith et al., 1995b). In
plied to a number of anatomical sites (Medawar, 1948). fact, the T cell component of the TNP–spl is responsible
It was believed these sites exist solely as a result of for the induction of immune deviation (Ferguson et al.,
physical barriers that concealed antigens from the im- 1987), similar to the cellular requirement for donor-spe-
mune system and prevented effector cell access. Al- cific transplantation tolerance (Hori et al., 1989). Third,
though in the eye the blood/ocular barrier is an effective the induction of immune deviation requires the presence
obstacle, it is now clear that the mechanisms of immune of an intact spleen (Streilein and Neiderkorn, 1981) for
privilege are much more complex. Many of the important the first 3–5 days following AC injection. Restoration of
studies into the molecular basis of immune privilege the spleen effect takes place only with splenic fragments
have been performed in the eye and it has been found (not dispersed spleen cells), implying that the architec-
that immune privilege relies on multiple factors, which ture is a critical factor.
work together to protect this vital organ from rampant A fourth component involved in tolerance induction
inflammatory processes. These include the production is the presence of theneuropeptide vasoactive intestinal
of immunosuppressive cytokines (Hooper et al., 1991; peptide (VIP) in the eye during the initiation of the re-
Wilbanks and Streilein, 1992; Wilbanks et al., 1992), the sponse (Ferguson et al., 1995; Taylor et al., 1994). We
localization of neuropeptides in ocular neurons (Fergu- do not know whether VIP directly participates in cell
son et al., 1995; Taylor et al., 1994), the strategic place- death, but it has recently been shown that VIP induces
ment of specialized antigen-presenting cells (Wilbanks adhesion in T cells via LFA-1/ICAM-1 and VLA-5/fibro-
et al., 1991; Kinesely et al., 1991), and the induction of nectin (Johnston et al., 1994). Thus, VIP may induce
systemic immune deviation following antigen presenta- inflammatory cells to adhere to ocular structures leading
tion in the eye (Ferguson et al., 1987, 1989, 1995; Kaplan to their apoptosis by FasL expressed on ocular tissue.
and Streilein, 1977; Sonada and Streilein, 1993; Streilein A fifth requirement for tolerance is a tolerogenic signal,
et al., 1987; Wetzig et al., 1982). generated in the eye (Griffith et al., 1995b; Wilbanks et
We have recently found that expression of FasL in al., 1991). This signal originates in the eye, enters the
the eye kills infiltrating Fas1 cells, and that acts as a venous circulation, and promotes the systemic toler-
ance by splenic localization. It has recently been shownsignificant protective mechanism for this organ (Griffith
Immunity
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Figure 5. TUNEL Stains from Mice 48 hr
Post-AC Injection with TNP–spl
(A) B6 TNP–spl injected into B6 eyes
(B) B6–lpr TNP–spl injected into B6 eyes.
(C) B6 TNP–spl injected into B6–gld eyes.
AC, anterior chamber; IR, iris; L, lens.
(Wilbanks et al., 1991) that antigen-laden macrophages numerous apoptotic cells 48 hr following antigen injec-
tion, all cells are gone by 72–96 hr (data not shown). It ismove from the eye to the spleen where tolerance is
induced. We have observed that while the eye contains possible that macrophages, laden with antigen (debris)
Apoptosis and Tolerance
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Figure 6. Tolerance Induction Requires
Apoptotic Cell Death
(A) TNP-coupled B6–lpr T cells were freeze/
thawed (F/T), g irradiated (g-irrad), heated
(heat), or fixed with 1% paraformaldehyde
(1% Para) prior to AC injection. Mice were
immunized 48 hr later with 1% TNCB on
shaved abdominal skin. Mice were chal-
lenged 5 days laterwith 0.033 ml 10 mM TNBS
in PBS in the right footpad and 0.033 ml PBS
in the left footpad. Measurements (microme-
ters 6 standard error) were taken 24 hr later
and represent the difference between right
footpad (antigen challenge) and left footpad
(PBS challenge). Background (Bkg) values
represent the difference between challenged
and unchallenged sites in naive mice.
(B) DNA fragmentation of treated B6–lpr T
cells used for injection in (A). Cells (106) were
treated as above and cultured overnight be-
fore DNA was extracted and resolved on a 2%
agarose gel. DNA was visualized by ethidium
bromide staining. Lane 1, untreated; lane 2,
freeze/thaw; lane 3, g irradiated; lane 4,
heated; lane 5, 1% paraformaldehyde fixed.
We do not know the precise mechanism by which cell
death in the eye leads to systemic tolerance, but we
propose several possibilities based on current models
of tolerance induction. First, the cell death observed in
the eye may result in the deletion of antigen-reactive
cells. It is known that Fas/FasL interactions are involved
in peripheral tolerance (Mogil et al., 1995; Singer and
Abbas, 1994); however, the cell death in the eye is so
rapid (within the first 48 hr) that it is unlikely that all
cells reactive to an antigen would traffic to the eye for
deletion. A second possibility is that the observed Fas/
FasL-mediated apoptosis deletes only the Th1 type
cells, while leaving intact the Th2 response. A recent
study has shown that Th1 clones are more susceptible
to Fas-mediated death than Th2 cells (Ramsdell et al.,
1994). Again, it is unlikely that all cells reactive to an
antigen migrate to the eye within the first few days of
an infection, resulting in the direct systemic deletion of
antigen-reactive Th1 cells. A third possibility is that the
effect is mediated through antigen-presenting cells that
engulf and present cellular debris in tolerogenic form to
the immune system. Perhaps antigen presentation in
the absence of costimulators, such as B7-1 or B7-2
(Thompson, 1995), leads to the induction of anergy, or
the preferential induction of antibody-inducing Th2 re-
sponses. The Th2 cells might then regulate the activity
of the DTH-mediating Th1 cells through the production
of interleukin-4 (IL-4) or IL-10. Support for this comes
from our observation (Table 1) that IFNg production was
dramatically inhibited by tolerance induction. This re-
duction might reflect the dominance of Th1 over Th2;
however, it should be noted that no such dominance
has been shown in this system. Also, CD41 (Wilbanks
and Streilein, 1990) and CD81 regulatory cells (Ferguson
et al., 1987; Wilbanks and Streilein, 1990) have beenfrom apoptotic cells, induce tolerance by lodging in the
observed. AC injection may lead to the activation ofmarginal zones of the spleen. We also can not rule out
CTLs that can kill Th1 DTH cells, or Th2 type CD81 cellsthe possibility that it is the apoptotic cells that leave the
that regulate CD41 cells by production of IL-10 (Sedereye and are removed by phagocytic cells in the spleen,
leading to tolerance. and LeGros, 1995) may be involved.
Immunity
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Laboratory (Bar Harbor, Maine). Bcl-xL transgenic mice (Chao et al.,
1995) were provided by Dr. S. Korsmeyer (Washington University).
In all in vivo experiments, groups consisted of 5 or more animals.
Experiments were repeated at least three times with similar results
before they were reported.
Reagents
TNCB was purchased from Eastern Chemical Company (Smithtown,
New York). TNBS was purchased from Sigma Chemical Company
(St. Louis, Missouri).
Preparation of Chimeric Mice
Radiation bone marrow chimeras were prepared as previously de-
scribed (Griffith et al., 1995a). In brief, mice received 11 Gy (1 Gy 5
100 rads) of radiation before receiving 107 bone marrow cells. Mice
were rested at least 3 weeks before use.
TNP Coupling of Cells
Red blood cell–free single cell suspensions from freshly isolated
spleens were coupled with TNP as previously described (Ferguson
et al., 1987, 1989). In brief, 108 spleen cells were incubated in 0.5
ml Hank’s balanced salt solution (HBSS) and 0.5 ml 10 mM TNBS
for 7–10 min at room temperature. After incubation, cells were
washed three times with HBSS before use.
Isolation of T Cells
Figure 7. Bcl-xL Expression in T Cells Blocks Tolerance T cells were isolated from spleen cell suspension as previously
B6 mice were AC injected with TNP–spl cells prepared from normal described (Ferguson et al., 1987, 1989). In brief, 5 ml econocolumns
B6 mice or Bcl-xL transgenic mice 48 hr prior to immunization with (Bio-Rad, Richmond, California) were filled with glass beads (mean
1% TNCB on shaved abdominal skin. Mice were challenged 5 days diameter, 200 mm) coated with normal mouse immunoglobulin. The
later with 0.033 ml 10 mM TNBS in PBS in the right footpad and columns were washed three times with HBSS, followed by the addi-
0.033 ml PBS in the left footpad. Measurements (micrometers 6 tion of a one-sixth diluted rabbit anti-mouse immunoglobulin. After
standard error) were taken 24 hr later and represent the difference 1 hr incubation, the column was washed three times with HBSS.
between right footpad (antigen challenge) and left footpad (PBS Spleen cells (108/2.5 ml beads) were added to the column with a
challenge). Background (Bkg) values represent the difference be- flow rate of one drop per 6–10 s. Cells were collected as they
tween challenged and unchallenged sites in naive mice. emerged from the column. Yields were typically 25%–30% of the
applied cells that consisted of 95%–98% CD31 cells.
Whatever the precise mechanism for the induction of HSV-1
The KOS strain of HSV-1 was propagated on Vero cells grown intolerance in this system, we believe our data show an
RPMI 1640 supplemented with 10% fetal calf serum (FCS), antibi-important link between the apoptosis of lymphoid cells
otic/antimycotic, glutamine, and 5 3 1025 M b-mercaptoethanol.in the eye and the induction of immune tolerance. There
Virus was titrated using a standard plaque-forming assay on Vero
are definitely parallels between immune privilege and cells and expressed as pfu/ml. UV-inactivated virus was prepared
tolerance, as recently suggested by Abbas (1996). The by exposing virus stocks to a UV lamp for 15 min at a distance of
ability of the eye to kill invading inflammatory cells helps 20 cm. This exposure was determined to inactivate completely the
virus as detected in the viral plaque assay.maintain immune privilege, while tolerance relies on the
ability of lymphocytes to kill themselves or each other
Induction of Immune Deviationduring an immune response. Our data show that the
Immune deviation was induced as described (Ferguson et al., 1987,
systems are not only parallel, but can rely on each other 1989; Griffith et al., 1995b). In brief, HSV-1 (KOS) (2.5 3 104 pfu) or
to regulate dangerous inflammatory reactions occurring TNP–spl (5 3 105) were injected into the AC in 0.005 ml volume
in important anatomical areas. Perhaps tolerance in- using a 0.25 ml Hamilton Microliter syringe (Hamilton Company,
Reno, Nevada) fitted with a 33 gauge needle. Mice were anesthetizedduced by apoptosis in immune-privileged sites is an
with Metofane (methoxyflurane) and injections were done under aimportant mechanism to prevent autoimmunity to the
dissecting microscope. For HSV-1-induced immune deviation, miceantigens in these areas that may not have been per-
were challenged 7–10 days later with 106 UV-inactivated virus (0.033
ceived in the thymus for clonal deletion. Our results also ml) in the right footpad, and with 0.033 ml phosphate-buffered saline
further emphasize that immune privilege is not simply (PBS) in the left footpad. For TNP–spl-induced immune deviation,
a passive process involving physical barriers, but is an mice were immunized 48 hr after AC injection with 0.050 ml of 1%
TNCB in acetone/olive oil (3/1) applied to shaved abdominal skin.active process that employs an important natural mech-
Mice were challenged 5 days later with 0.033 ml 10 mM TNBS inanism to induce cell death leading to the induction of
PBS in the right footpad and 0.033ml PBS in the left footpad. Forimmune tolerance. The consequences for the eye are
both antigen systems, values are expressed in micrometers (6 stan-
significant, since the ultimate result is the maintenance dard error) and represent the difference between the right footpad
of the visual integrity. (antigen challenge) and the left footpad (PBS challenge). Back-
ground values represent the difference between the challenged and
unchallenged foot in unimmunized mice.
Experimental Procedures
In Situ TUNEL Staining
Eyes were removed, fixed in formalin, and processed for paraffinMice
C57BL/6 were purchased from the National Cancer Institute. C57BL/ sectioning 24 and 48 hr after AC injection of cells. Sections (10 mm)
were mounted onto microscope slides and incubated overnight at6–lpr and C57BL/6–gld mice were purchased from The Jackson
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558C. Sections were then deparaffinized for 2 3 5 min in xylene, Ferguson, T., Waldrep, J.C., and Kaplan, H.J. (1987). The immune
response and the eye. II. The nature of T suppressor cell induction in2 3 5 min in absolute ethanol, 3 min in 95% ethanol, 3 min in 70%
ethanol, and 5 min in PBS. Protein present in the sections was anterior chamber associated immune deviation (ACAID).J. Immunol.
139, 352–357.digested with 20 mg/ml proteinase K for 15 min at room temperature.
Following four washes in distilled water, endogenous peroxidase Ferguson, T.A., Hayashi, J., and Kaplan, H.J. (1989). The immune
was quenched with 2.0% H2O2 for 5 min at room temperature and response and the eye. III. Anterior chamber associated immune
sections were washed two times in PBS. Labeling of 39-OH frag- deviation can be adoptively transferred by serum. J. Immunol. 143,
mented DNA ends was performed with an in situ apoptosis detection 821–826.
kit (ApopTag, Oncor, Gaithersburg, Maryland) following the instruc- Ferguson, T.A., Herndon, J.M., and Dube, P. (1994). The immune
tions of the manufacturer. Detection of labeled ends was done with response and the eye. IV. A role for tumor necrosis factor in anterior
anti-digoxigenin-peroxidase antibody and DAB substrate (DAB sub- chamber associated immune deviation. Invest. Ophthal. Vis. Sci. 35,
strate kit, Vector, Burlingham, California) (Gavriele et al., 1992). 2643–2651.
Ferguson, T.A., Fletcher, S., Herndon, J.M., and Griffith, T.S.. (1995).Determination of DNA Fragmentation
Neuropeptides modulate immune deviation induced via the anteriorT cells were treated with 30 Gy irradiation, heated to 568C for 30 min,
chamber of the eye. J. Immunol. 155, 1746–1756.fixed with 1% paraformaldehyde for 20 min at room temperature, or
Gavriele, Y., Sherman, Y., and Ben-Sasson, S.A. (1992). Identificationfrozen and thawed. Cells were then cultured overnight in RPMI 1640
of programmed cell death in situ via specific labeling of nuclearplus 10% FCS. Cells were pelleted and resuspended in 0.5 ml of
DNA fragmentation. J. Cell Biol. 119, 493–501.DNA lysis solution (50 mM Tris [pH 8], 10 mM EDTA, 200 mM NaCl,
0.5% SDS) with 0.012 ml proteinase K (20 mg/ml). The mixture was Griffith, T.S., Brunner, T., Fletcher, S.M., Green, D.R., and Ferguson,
T.A. (1995a). Fas ligand–induced apoptosis as a mechanism of im-incubated for 1 hr at 608C followed by overnight incubation at 378C.
Samples were extracted in phenol/chloroform and theaqueous layer mune privilege. Science 270, 1189–1192.
precipitated in an equal volume of isopropanol at 2208C. After wash- Griffith, T.S., Herndon, J.M., Lima, J., Kahn, M., and Ferguson, T.A.
ing in 70% EtOH, the pellet was dried and resuspended in 0.050 ml (1995b). The immune response and the eye: T cell receptor a–chain
TE plus 0.0045 ml RNAse A (10 mg/ml). Samples were incubated related molecules regulate the systemic immunity to antigen pre-
for 90 min at 378C and then electrophoresed on a 2% agarose gel. sented via the anterior chamber of the eye. Int. Immunol. 7, 1617–
DNA was visualized by ethidium bromide staining. 1625.
Hooper, P., Bora, N., Kaplan, H.J., and Ferguson, T.A. (1991). Inhibi-
Measurement of Cytokine Production tion of lymphocyte proliferation by resident ocular cells. Curr. Eye
B6 and B6–gld were immunized AC, subcutaneously, or intraperito- Res. 10, 363–372.
neally with 2.5 3 104 pfu HSV-1. After 7 days, spleens were removed
Hori, S., Sato, S., Kitagawa, S., Azuma, T., Kokudo, S., Hamaoka,and single cell suspensions were cultured with 1 3 106 UV-inacti-
T., and Fujiwara, H. (1989). Tolerance induction of allo-class II H-2vated HSV-1 in RPMI 1640 plus 10% FCS. Samples of the culture
antigen reactive L3T41 helper T cells and prolonged survival of thesupernatant were removed at 24 and 48 hr and tested for the pres-
corresponding class II H-2-disparate skin graft. J. Immunol. 143,ence of IFNg. Serial dilution of recombinant IFNg or supernatant
1447–1452.from stimulated spleen cells were added to wells of 4 3 103 WEHI-
Iwai, K., Miyawaki, T., Takizawa, T., Konno, A., Ohta, K., Yachie, A.,279 cells in DMEM with 10% FCS. Cultures were incubated for 40
Seki, H., and Taniguchi, N. (1994). Differential expression of Bcl-2hr at 378C in 5% CO2, followed by an 8 hr pulse with 1 mCi [3H]TdR,
and susceptibility to anti-Fas-mediated cell death in peripheraland harvested for scintillation counting. Growth inhibition of WEHI-
blood lymphocytes, monocytes, and neutrophils. Blood 4, 1201–279 reflected the amount of IFNg, and unknown samples were com-
1208.pared with the standard curve constructed from the values in units/
ml obtained with the recombinant IFNg. Johnston, J.A., Taub, D.D., Lloyd, A., Conlon, K., Oppenheim, J.J.,
and Kevlin, D.J. (1994). Human T lymphocyte chemotaxis and adhe-
sion induced by vasoactive intestinal peptide. J. Immunol. 153,Statistical Analysis
1762–1768.Significant differences between groups were evaluated using a two-
tailed Student’s t test (p < 0.01). Kaplan, H.J., and Streilein, J.W. (1977). Immune response to immuni-
zation via the anterior chamber of the eye: I. F1-lymphocyte induced
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